نتایج جستجو برای: ibritumomab tiuxetan
تعداد نتایج: 246 فیلتر نتایج به سال:
Journal:
:Blood
2014
Arne Kolstad
Anna Laurell
Mats Jerkeman
Kirsten Grønbæk
Erkki Elonen
Riikka Räty
Lone Bredo Pedersen
Annika Loft
Trond Velde Bogsrud
Eva Kimby
Per Boye Hansen
Unn-Merete Fagerli
Herman Nilsson-Ehle
Grete Fossum Lauritzsen
Anne Kristine Lehmann
Christer Sundstrom
Marja-Liisa Karjalainen-Lindsberg
Elisabeth Ralfkiaer
Mats Ehinger
Jan Delabie
Hans Bentzen
Jukka Schildt
Kamelia Kostova-Aherdan
Henrik Frederiksen
Peter de Nully Brown
Christian H Geisler
The main objective of the MCL3 study was to improve outcome for patients not in complete remission (CR) before transplant by adding (90)Y-ibritumomab-tiuxetan (Zevalin) to the high-dose regimen. One hundred sixty untreated, stage II-IV mantle cell lymphoma patients <66 years received rituximab (R)-maxi-CHOP (cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone) alternating with R-...
Journal:
:Physics in Medicine and Biology
2014
Journal:
:British Journal of Haematology
2007
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید